Evidence map›Paper›PMID 35106510›Full record

ArticleCell reports. Medicine2022

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism.

Yiming Zhang, Cassandra B Higgins, Brian A Van Tine, John S Bomalaski, Brian J DeBosch

Open access · goldAbstract read
In one paragraph

Article in Cell reports. Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yiming ZhangDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cassandra B HigginsDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Brian A Van TineDivision of Medical Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.
John S BomalaskiPolaris Pharmaceuticals, Inc., San Diego, CA 63110, USA.
Brian J DeBoschDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Washington University in St. Louis · USPolaris (United States) · USSt. Louis Children's Hospital · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Rodney D Newberry · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Nada A. Abumrad · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
Pediatric Gastroenterology Research Training ProgramT32DK077653 · NIDDK · WASHINGTON UNIVERSITY · PI PHILLIP I TARR · 2007 to 2026
$5.8M
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting responseR01HL147968 · NHLBI · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2020 to 2024
$3.2M
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolismR01DK126622 · NIDDK · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2021 to 2024
$1.7M
Biological Effects and Mechanistic Actions of the Natural Disaccharide and Dietary Supplement, Trehalose.R21AT010520 · NCCIH · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2019 to 2020
$432k
Leveraging glucose transport and the adaptive fasting response to modulate hepatic metabolismR56DK115764 · NIDDK · WASHINGTON UNIVERSITY · PI DEBOSCH, BRIAN JESSE · 2018 to 2018
$381k
Leveraging arginine catabolism to treat metabolic diseasesF31DK131875 · NIDDK · WASHINGTON UNIVERSITY · PI ZHANG, YIMING · 2021 to 2024
$143k
NCATS NIH HHS UL1 TR002345NCCIH NIH HHS R21 AT010520NHLBI NIH HHS R01 HL147968NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK126622NIDDK NIH HHS R56 DK115764NIDDK NIH HHS T32 DK077653
6 · The paper itself

Abstract

Obesity is a multi-systemic disorder of energy balance. Despite intense investigation, the determinants of energy homeostasis remain incompletely understood, and efficacious treatments against obesity and its complications are lacking. Here, we demonstrate that conferred arginine iminohydrolysis by the bacterial virulence factor and arginine deiminase,

Indexed as

AutophagyEnergy MetabolismAnimalsArginineBeclin-1DependovirusDiabetes Mellitus, ExperimentalDiet, WesternDyslipidemiasFatty LiverFibroblast Growth FactorsGlucoseHepatocytesHomeostasisHydrolasesInsulin ResistanceADI PEG20Argininearginine deiminaseBeclin-1fibroblast growth factor 21Fibroblast Growth FactorsGlucoseHydrolasesPolyethylene GlycolsADI-PEG 20arcAarginaseargininearginine deiminaseautophagyBeclin-1caloric restrictiondiabetesenergy metabolismfastingFGF21glucose transportGLUTinsulin resistancelivernon-alcoholic fatty liver diseaseobesitythermogenesis

Identifiers

PMID35106510
PMCPMC8784773
OpenAlexW4206827212

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.